Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolic ...
Clinical Trials Arena on MSN16h
Blue Earth’s radioligand therapy achieves high tumour radiation absorptionResults from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.
Keras/Tensorflow implementation of TP-GAN for automating treatment planning for low-dose-rate prostate brachytherapy. This work has been published in Medical Image ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback